Pfizer breast cancer treatment granted FDA priority review status

October 13, 2014 4:01 PM

6 0

Pfizer breast cancer treatment granted FDA priority review status

Potentially speeds up approval process by up to four months

Pfizer Inc. said Monday that its experimental breast-cancer treatment, palbociclib, has been granted priority review by the U.S. Food and Drug Administration, potentially speeding the approval process by up to four months.

Read more

To category page

Loading...